Background: Substance Use Disorder (SUD) is more prevalent among individuals with psychotic disorders than in the general population and is associated with poorer functioning, treatment adherence, and outcomes. Understanding motives for substance use in this group is essential for targeted interventions. Methods: Motives were assessed using the 26-item Reasons for Substance Use Questionnaire in 118 male patients admitted for a psychotic episode between October 2024 and September 2025. Results: In total, 20.3% of the participants were first-admission patients. Enhancement motives were most frequently endorsed, followed by coping and social motives; conformity and relief were least endorsed. In exploratory unadjusted analyses, patients with multiple hospital admissions reported greater relief related motives, including alleviating positive symptoms and medication side effects. Motives varied by primary substance used. Conclusions: Mood enhancement and coping were predominant motives; relief motives appeared to be stronger in patients with multiple admissions. Further research is needed to improve treatment strategies.

Personality disorders (PDs) are common in psychiatric populations but often remain underrecognized in routine practice, which can affect treatment and outcomes. This study examined the gap between screening results and documented diagnoses among psychiatric inpatients in Romania and explored their links with rehospitalization. Ninety-four patients completed the structured clinical interview for diagnostic and statistical manual of mental disorders, fifth edition screening personality questionnaire (SCID-5-SPQ), and existing diagnoses were extracted from hospital records. More than half of participants (59.6%) screened positive, yet only one patient (1.1%) had a recorded diagnosis, indicating very low concordance (1.8%). Patients screening positive seemed to have higher mean rehospitalization rates, although this difference was not statistically significant (p = .160). Dimensional scores showed modest but significant correlations with hospitalization frequency (ρ = .25-.29, p < .05) but were not significant predictors in regression analyses. These findings suggest a substantial gap in recognition of PDs in clinical settings and indicate the utility of brief screening tools in improving detection and guiding psychiatric care.

Mood disorder symptoms represent an important but understudied mental health concern among physicians in Romania, with potential implications for quality of life and suicide risk. This cross-sectional study included 104 medical doctors. Validated self-report instruments were used to assess depressive symptoms, manic and cyclothymic symptoms, bipolar risk, suicidal behaviour, and quality of life. Pearson correlation analyses and multiple linear regression models were conducted to examine associations and identify predictors of quality of life and suicide risk. Overall, 33% of participants screened positive for depressive symptoms, 21% for manic symptoms, 71% for cyclothymic symptoms, 12% for suicide risk, and 2% for bipolar risk. Depression, cyclothymia, and suicide risk were negatively correlated with quality of life, whereas manic symptoms showed a positive association. In multivariate analyses, cyclothymia predicted poorer quality of life (β = −0.43, p < 0.001) and manic symptoms seemed to predict better quality of life (β = 0.26, p = 0.008), while depressive symptoms uniquely predicted greater suicide risk (β = 0.24, p = 0.048). These findings indicate a high prevalence of mood disorders among Romanian physicians and suggest distinct patterns linking mood symptoms to quality of life and suicide risk. The results highlight the importance of early identification, stigma reduction, and targeted mental health interventions to support physician well-being and healthcare system sustainability.